Hennion & Walsh Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $447K | Sell |
|
|||||
|
2025
Q1 | $1.84M | Sell |
|
|||||
|
2024
Q4 | $2.14M | Sell |
|
|||||
|
2024
Q3 | $2.53M | Sell |
|
|||||
|
2024
Q2 | $3.98M | Sell |
|
|||||
|
2024
Q1 | $5.9M | Buy |
|
|||||
|
2023
Q4 | $3.9M | Sell |
|
|||||
|
2023
Q3 | $5.9M | Buy |
|
|||||
|
2023
Q2 | $5.83M | Buy |
|
|||||
|
2023
Q1 | $3.62M | Buy |
|
|||||
|
2022
Q4 | $3.58M | Buy |
|
|||||
|
2022
Q3 | $2.83M | Buy |
|
|||||
|
2022
Q2 | $2.17M | Buy |
|
|||||
|
2022
Q1 | $1.55M | Buy |
|
|||||
|
2021
Q4 | $989K | Buy |
|